ArticleFrontiers in oncology2026
Case Report: Cardiac angiosarcoma with rib pain as the first symptom.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Primary cardiac angiosarcoma (PCAS) is a rare, highly aggressive malignancy characterized by a dismal prognosis. We present a case of a 34-year-old woman with no history of trauma who initially presented with persistent rib pain misdiagnosed as costochondritis. Comprehensive evaluation revealed multiple osteolytic bone metastases originating from a right atrial PCAS, accompanied by circumferential pericardial effusion. Despite initiation of palliative chemotherapy and radiotherapy, the patient succumbed to progressive disease five months after diagnosis. This case underscores three critical clinical considerations: (1) metastatic bone involvement may manifest solely as localized, refractory pain; (2) isolated pain without overt cardiac symptoms poses significant diagnostic challenges and risks delayed recognition; and (3) unexplained bone pain-particularly when concurrent with pericardial effusion-warrants prompt multimodal imaging and interdisciplinary evaluation involving oncology, cardiology, and pain medicine. By detailing the clinical, radiological, and histopathological findings, we aim to raise awareness among pain specialists and oncologists of this rare yet life-threatening cardiac malignancy and to advocate earlier diagnostic suspicion in atypical pain presentations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.